260 related articles for article (PubMed ID: 29514145)
1. Preoperative Midregional Pro-Adrenomedullin and High-Sensitivity Troponin T Predict Perioperative Cardiovascular Events in Noncardiac Surgery.
Golubović M; Janković R; Sokolović D; Ćosić V; Maravić-Stojkovic V; Kostić T; Perišić Z; Lađević N
Med Princ Pract; 2018; 27(3):278-284. PubMed ID: 29514145
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin Is Associated With Surgical Trauma and Impaired Renal Function in Vascular Surgery Patients.
Gillmann HJ; Meinders A; Larmann J; Sahlmann B; Schrimpf C; Aper T; Lichtinghagen R; Teebken OE; Theilmeier G
J Intensive Care Med; 2019 Jan; 34(1):67-76. PubMed ID: 28110613
[TBL] [Abstract][Full Text] [Related]
3. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
Shah KS; Marston NA; Mueller C; Neath SX; Christenson RH; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney J; Schreiber D; deFilippi C; Hogan CJ; Diercks DB; Limkakeng A; Anand IS; Wu AH; Clopton P; Jaffe AS; Peacock WF; Maisel AS
Acad Emerg Med; 2015 May; 22(5):554-63. PubMed ID: 25908114
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.
Lundberg OH; Bergenzaun L; Rydén J; Rosenqvist M; Melander O; Chew MS
Crit Care; 2016 Jun; 20(1):178. PubMed ID: 27282767
[TBL] [Abstract][Full Text] [Related]
5. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
[TBL] [Abstract][Full Text] [Related]
8. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
[TBL] [Abstract][Full Text] [Related]
10. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
[TBL] [Abstract][Full Text] [Related]
12. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
14. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
[TBL] [Abstract][Full Text] [Related]
15. Circulating adrenomedullin and B-type natriuretic peptide do not predict blood pressure fluctuations during pheochromocytoma resection: a cross-sectional study.
Berends AMA; Buitenwerf E; Riphagen IJ; Lenders JWM; Timmers HJLM; Kruijff S; Links TP; van der Horst-Schrivers ANA; Stegeman CA; Eekhoff EMW; Feelders RA; Corssmit EPM; Groote Veldman R; Haak HR; Muller Kobold AC; Kerstens MN
Eur J Endocrinol; 2021 Aug; 185(4):507-514. PubMed ID: 34324433
[TBL] [Abstract][Full Text] [Related]
16. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.
Smilowitz NR; Berger JS
JAMA; 2020 Jul; 324(3):279-290. PubMed ID: 32692391
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
